China smartphone shipments slumped in June on inventory overhang: Jefferies
Nicholas B. Hawkins (NASDAQ:HWKN), the Vice President and Chief Financial Officer of Arteris , Inc. (NASDAQ:AIP), a company maintaining strong gross profit margins of nearly 90% and a healthy balance sheet with more cash than debt, has sold a portion of his holdings in the company. According to InvestingPro analysis, the stock is currently trading above its Fair Value amid a challenging week that saw shares decline over 13%. According to a recent SEC filing, Hawkins sold 690 shares of common stock on March 6, 2025, at a price of $8.17 per share, totaling $5,637. This transaction was conducted under a 10b5-1 trading plan, which provides a pre-determined schedule for selling stocks, adopted by Hawkins on May 20, 2024. Following this sale, Hawkins holds 185,433 shares of Arteris stock directly. For comprehensive insider trading analysis and additional insights, including 7 more exclusive ProTips, check out the detailed research report available on InvestingPro.
In other recent news, Arteris, Inc. has been the focus of analysts following its recent product launches and market activities. Jefferies has adjusted its price target for Arteris to $11.00, up from $7.00, while maintaining a Hold rating. This adjustment reflects Arteris’ progress in the microcontroller unit market and the introduction of its FlexGen solution, which is expected to increase the average selling price per license by 30%. Northland analysts also raised their price target for Arteris, increasing it to $16.00 from $14.00, and maintained an Outperform rating. They highlighted that Arteris’ revenue met expectations, with bookings around $33.6 million for the quarter, and a book-to-bill ratio of 2.2:1. The FlexNoC 5 product accounted for a significant portion of the interconnect licenses, showing strong market traction. The launch of FlexGen, which 13 customers are currently evaluating, is seen as a driver for future revenue growth. Both firms noted the potential impact of FlexGen on Arteris’ financial performance, with Northland expressing confidence in the company’s market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.